Vaccines

A vaccine is an experimental strategy that aims to teach the body's immune system how to fight HIV.

PHRU’s HIV/AIDS Vaccine Division (HAVD) has been conducting groundbreaking HIV vaccine research since it was founded in 2001. Originally established with funding from the International AIDS Vaccine Initiative (IAVI), South African AIDS Vaccine Initiative (SAAVI) and later with funding provided by the US National Institutes for Health and the HIV Vaccine Trials Network (HVTN), the dedicated vaccine division aims to:

• Conduct multiple, parallel phase I/II (safety) trials according to Good Clinical Practice guidelines in order to identify appropriate preventative and therapeutic phase III (efficacy) trial candidates
• Develop phase III capability both in rural and urban centres in South Africa
• Enable multi-centred, African collaborations to conduct HIV vaccine research in Africa, especially large phase III efficacy trials

Clinical Trials and Research

PHRU conducts HIV vaccine trials in partnership with the International AIDS Vaccine Initiative, the US National Institutes of Health, academic and other publicly funded institutions and as part of the HIV Vaccine Trials Network (HVTN).

Learn more about our ongoing clinical trials and research studies.

HIV Vaccine Trials Network (HVTN): Soweto Clinical Research Site.

Health Information

Learn more about HIV vaccines.